Patent · US Active

Kits comprising linear DNAs for sustained polypeptide expression using synthetic, modified RNAs

US8883506B2 · kind B2 · utility

153Cited by
8References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 21, 2012
Grant dateNov 11, 2014
Priority date
Expiry dateOct 1, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are synthetic, modified RNAs for changing the phenotype of a cell, such as expressing a polypeptide or altering the developmental potential. Accordingly, provided herein are compositions, methods, and kits comprising synthetic, modified RNAs for changing the phenotype of a cell or cells. These methods, compositions, and kits comprising synthetic, modified RNAs can be used either to express a desired protein in a cell or tissue, or to change the differentiated phenotype of a cell to that of another, desired cell type.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.